EP Patent

EP2061750A2 — Improved process for synthesizing desvenlafaxine free base and salts or solvates thereof

Assigned to Medichem SA · Expires 2009-05-27 · 17y expired

What this patent protects

The invention relates generally to an improved process for manufacturing desvenlafaxine free base and salts or solvates thereof.

USPTO Abstract

The invention relates generally to an improved process for manufacturing desvenlafaxine free base and salts or solvates thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP2061750A2
Jurisdiction
EP
Classification
—
Expires
2009-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Medichem SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.